["{\n\"step_by_step_thinking\": \"The provided documents are related to various medical conditions such as diabetes, cancer, and hyperfibrinolysis. Since the question is about natalizumab's effect on secondary progressive multiple sclerosis, there is no direct relevance to any of these conditions. Therefore, it cannot be concluded that natalizumab improves disease course of secondary progressive multiple sclerosis.\",\n\"answer_choice\": \"B\"\n}"]